Lataa...
Risk of intracranial hypertension with intrauterine levonorgestrel
OBJECTIVES: The objective of this study was to quantify the risk of intracranial hypertension (ICH) with the intrauterine levonorgestrel (IUL) device Mirena(®). METHODS: We used the United States Food and Drug Administration’s Adverse Events Reporting System (FAERS) database to quantify a reporting...
Tallennettuna:
| Julkaisussa: | Ther Adv Drug Saf |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4519742/ https://ncbi.nlm.nih.gov/pubmed/26240745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098615588084 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|